Logo
homeHome
toggle_offCompany ProfilegroupsBoards & Staffsworkspace_premiumMemberships & PartnersschoolAcademy of Journalismperson_addCareerslinkBlog(EN)emailContact Us
list_altOur JournalslightbulbInstruction for AuthorsbookmarkBrieflands PolicieshandshakePublish My Researchplay_circleJournal Management Systemcredit_cardArticle Processing Chargeszoom_inOpen Peer ReviewimagePublishing Services
menu_bookPublish My Book
  1. Brieflands
  2. journals
  3. Journal of Reports in Pharmaceutical Sciences
  4. Articles

  5. Synthesis and In Vitro Anti-Leishmanial Evaluation of 1 -( 5 - Halo- 2 -Thienyl)- 2 -[5 -(5-Nitroheteroaryl)]-1 ,3 ,4 -Thiadiazol- 2 - Ylthio)Ethanone Derivatives
  6. Scopus by Title (Ref)

Journal of Reports in Pharmaceutical Sciences

homeHome
play_arrowCurrent IssuelistAll Issuespicture_as_pdfIn Presscheck_circleAccepted ManuscriptssearchSearch
lightbulbInstructions
infoJournal InformationgroupsEditors & BoardspublicIndexing and Listing Sourcesbar_chartJournal Metricszoom_inOpen Peer Review (OPR)balancePublication Ethics and Publication Malpractice Statementassignment_indReviewer and AE Registration FormemailSupportphoneContact Us
euroAPCcampaignAnnouncement of New Publisher
Authors GuideSubmit Manuscript

Scopus by Title (Ref)


1. Recent advances in the synthesis and development of nitroaromatics as anti-infective drugs

- Kannigadu C. , et al.

2. Thiadiazoles: The appropriate pharmacological scaffolds with leishmanicidal and antimalarial activities: A review

- Tahghighi A. , et al.

HomeInstructionsAPCAnnouncement of New Publisher

Articles

  • Current Issue
  • All Issues
  • In Press
  • Accepted Manuscripts
  • Search

About Journal

  • Journal Information
  • Editors & Boards
  • Indexing and Listing Sources
  • Journal Metrics
  • Open Peer Review (OPR)
  • Publication Ethics and Publication Malpractice Statement
  • Reviewer and AE Registration Form
  • Support
  • Contact Us
Support
Submit a Ticket
BrieflandsBrieflands

Science, Technical, Medical Publisher, Since 2007

All rights reserved by Brieflands, 2026.

Powered by Neoscriber.